Research Article
[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease
Table 3
Effect of glucocorticoid on IgA nephropathy patients with proteinuria greater than 1.50 g/d.
| Glucocorticoid group | Control group | Std. mean difference | Study or subgroup | Mean | SD | Total | Mean | SD | Total | Weight | IV, fixed, 95% CI |
| Locatelli et al., 2001 | 0.67 | 0.5 | 43 | 1.48 | 1.87 | 43 | 60.7% | −0.59 [−1.02,−0.15] | Moriyama et al., 2004 | 1.02 | 0.98 | 20 | 1.28 | 2.19 | 40 | 39.3% | −0.14 [−0.67, 0.40] | Total (95% CI) | | | 63 | | | 83 | 100.0% | −0.41 [−0.75,−0.07] |
|
|
Heterogeneity: Chi’ = 1.64, df = 1 ( = 0.20); I2 = 39%. Test for overall effect: Z = 2.38 ( = 0.02). |